Page last updated: 2024-11-04

sevoflurane and Bile Duct Cancer

sevoflurane has been researched along with Bile Duct Cancer in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"Our study found that sevoflurane inhibited cholangiocarcinoma cell proliferation in a dose-dependent manner."8.31Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway. ( Cheng, H; Li, Q, 2023)
"Our study found that sevoflurane inhibited cholangiocarcinoma cell proliferation in a dose-dependent manner."4.31Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway. ( Cheng, H; Li, Q, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, H1
Li, Q1

Other Studies

1 other study available for sevoflurane and Bile Duct Cancer

ArticleYear
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway.
    BMC gastroenterology, 2023, Aug-11, Volume: 23, Issue:1

    Topics: Apoptosis; beta Catenin; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movem

2023